Pfizer Statistics Program logo

Senior Director, Team Lead, KAT6i (Prifetrastat), US Breast Cancer

Pfizer Statistics Program

New York, NY; Collegeville, PAHybridPosted 1 day ago$214,900 - $358,100/year
Full TimeDirector & AboveCommercial & Pharma SalesPharmaceutical
Original posting ↗

Summary

Pfizer Commercial Oncology is building the next generation of breast cancer medicines, including prifetrastat (PF-07248144), a first-in-class KAT6 inhibitor in Phase 3 for HR+/HER2- advanced breast cancer after prior CDK4/6 inhibitor therapy. This role builds the commercial foundation for prifetrastat so that customers, accounts and the field are ready when it reaches the market, and ensures its strategy connects to the first-line CDK franchise.

Job description

Role Summary

Pfizer Commercial Oncology is building the next generation of breast cancer medicines, including prifetrastat (PF-07248144), a first-in-class KAT6 inhibitor in Phase 3 for HR+/HER2- advanced breast cancer after prior CDK4/6 inhibitor therapy. This role builds the commercial foundation for prifetrastat so that customers, accounts and the field are ready when it reaches the market, and ensures its strategy connects to the first-line CDK franchise.

Role Responsibilities

This Senior Director, Team Lead role reports to the VP, US Breast Cancer Franchise Lead and owns US launch preparation for prifetrastat, leading a team of up to 3–4 marketers at the Director and Sr. Manager level, including a dedicated launch lead.

Build the prifetrastat launch foundation

  • Own the prifetrastat pre-launch P&L and launch budget: build the long-range forecast and investment case, manage OpEx and resource allocation through launch, and establish financial discipline.
  • Lead US commercial strategy in a complex shifting landscape, including target product profile input, positioning, segmentation, target customers and the HCP and account launch plan.
  • Assess the market landscape with CtDNA & competitive entrants into the post-CDK 4/6 treatment paradigm.
  • Shape the market ahead of approval with disease-state education on post-CDK4/6 progression and KAT6 biology, and pre-launch engagement with key customers and advocacy groups.
  • Turn the brand strategy into workstreams addressing launch-critical issues: differentiation, biomarker testing readiness, tolerability and dose-management support, and customer value.
  • Define launch-readiness milestones, evidence needs and the investment case in partnership with Clinical Development, Market Access, Commercial Insights and Sales.

Build access and the patient foundation

  • Partner with Market Access, Pricing and Trade to shape pricing and contracting strategy, channel and distribution model, and gross-to-net plan.
  • Build the patient and advocacy strategy, including DTC/DTP, patient support and adherence programs, with tolerability and dose management designed in.

Connect the launch to the franchise

  • Map the patient journey from first-line CDK4/6 inhibitor use to post-CDK4/6 treatment so franchise strategies reinforce each other.
  • Align with BC Sales and KAD leadership on how prifetrastat enters annual POAs and field focus.
  • Lead the customer insight plan in partnership with analytics, CFCs and cross-functional partners.
  • Drive innovation and build new approaches, with a particular focus on AI and the go-to-market model.

Lead people and the franchise

  • Manage, engage and coach the team to achieve high performance and maximize team potential, and plan roles, development and succession.
  • Foster a positive team culture and collaboration across the broader US BC marketing team.
  • Participate in leadership presentations, performance updates and OpEx management.

Requirements

  • Bachelor's degree required and 12+ years of pharmaceutical industry experience, or Master's degree and 10+ years, or Ph.D./PharmD
  • US marketing experience with focus on HCP stakeholders, including pre-launch or launch work
  • Deep understanding of US market dynamics including specialty channels, organized customers and payers
  • Demonstrated success developing, executing and measuring complex marketing programs and championing innovative solutions
  • Proven track record of identifying customer needs and translating key insights into strategies and tactics
  • 5+ years of direct or matrix management or coaching of marketing colleagues at all levels (Manager to Director)
  • Collaborative team player with ability to engage experts from cross-functional areas
  • Demonstrated use of AI and advanced analytics to sharpen customer insight, targeting, forecasting and investment decisions
  • Strong analytical skills; detail and action oriented, creative, flexible, self-motivated
  • Excellent verbal and written communication skills for a wide range of audiences
  • Ability to travel domestically and internationally up to 25%

Benefits

  • 401(k) Matching
  • Retirement Savings Contribution
  • Paid Vacation
  • Paid Holidays
  • Paid Personal Days
  • Paid Caregiver/Parental Leave
  • Paid Medical Leave
  • Medical, Dental & Vision
  • Prescription Drug Coverage
  • Long-Term Incentive Program
  • Bonus Target 22.5%

Company overview

The Pfizer Statistics Program represents the statistical and data sciences functions within Pfizer Inc., one of the world's premier biopharmaceutical companies. This specialized program encompasses both the statistical analysis capabilities that support Pfizer's drug development pipeline and the educational initiatives like the Breakthrough Fellowship Program that includes MS Statistics components. As part of Pfizer's Research & Development organization, the Statistics Program plays a critical role in clinical trial design, data analysis, regulatory submissions, and evidence generation for Pfizer's innovative medicines and vaccines. The program employs advanced statistical methodologies and data science techniques to ensure the scientific rigor and integrity of Pfizer's clinical research across therapeutic areas including oncology, internal medicine, immunology, and vaccines. Through its integration with Pfizer's global operations, the Statistics Program contributes to the company's mission of delivering breakthroughs that change patients' lives by providing robust statistical support from early discovery through post-marketing surveillance.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.